[Source: Research & Innovation] Most vaccines need to be kept cool during transport and storage, but this can be hard to accomplish. EU-funded researchers keen to tackle this healthcare challenge have developed heat-tolerant and even needle-free formulations of an HIV-1 vaccine candidate. They expect their processes to work for many other vaccines as well.
from EUROPA - Syndicated Research News Feed https://ift.tt/2P39wFa
via IFTTT
No comments:
Post a Comment